117 related articles for article (PubMed ID: 24343902)
1. Transcriptomic analysis by RNA-seq reveals AP-1 pathway as key regulator that green tea may rely on to inhibit lung tumorigenesis.
Pan J; Zhang Q; Xiong D; Vedell P; Yan Y; Jiang H; Cui P; Ding F; Tichelaar JW; Wang Y; Lubet RA; You M
Mol Carcinog; 2014 Jan; 53(1):19-29. PubMed ID: 24343902
[TBL] [Abstract][Full Text] [Related]
2. Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.
Matthews CP; Birkholz AM; Baker AR; Perella CM; Beck GR; Young MR; Colburn NH
Cancer Res; 2007 Mar; 67(6):2430-8. PubMed ID: 17363560
[TBL] [Abstract][Full Text] [Related]
3. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
4. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
5. cFos is critical for MCF-7 breast cancer cell growth.
Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH
Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins.
Dong Z; Ma W; Huang C; Yang CS
Cancer Res; 1997 Oct; 57(19):4414-9. PubMed ID: 9331105
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved.
Chung JY; Huang C; Meng X; Dong Z; Yang CS
Cancer Res; 1999 Sep; 59(18):4610-7. PubMed ID: 10493515
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells.
Kikuchi J; Kinoshita I; Shimizu Y; Oizumi S; Nishimura M; Birrer MJ; Dosaka-Akita H
Br J Cancer; 2008 Dec; 99(12):2013-9. PubMed ID: 19018257
[TBL] [Abstract][Full Text] [Related]
9. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model.
Cooper SJ; MacGowan J; Ranger-Moore J; Young MR; Colburn NH; Bowden GT
Mol Cancer Res; 2003 Sep; 1(11):848-54. PubMed ID: 14517347
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expression.
Maritz MF; van der Watt PJ; Holderness N; Birrer MJ; Leaner VD
Biol Chem; 2011 May; 392(5):439-48. PubMed ID: 21417953
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
12. p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells.
Leaner VD; Donninger H; Ellis CA; Clark GJ; Birrer MJ
Mol Cell Biol; 2005 Apr; 25(8):3324-37. PubMed ID: 15798216
[TBL] [Abstract][Full Text] [Related]
13. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of UVB-induced AP-1 and NF-kappaB transactivation by components of the jun bZIP domain.
Cooper S; Ranger-Moore J; Bowden TG
Mol Carcinog; 2005 Jun; 43(2):108-16. PubMed ID: 15791649
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers.
Schuller HM; Porter B; Riechert A; Walker K; Schmoyer R
Lung Cancer; 2004 Jul; 45(1):11-8. PubMed ID: 15196729
[TBL] [Abstract][Full Text] [Related]
16. A dominant-negative c-jun mutant inhibits lung carcinogenesis in mice.
Tichelaar JW; Yan Y; Tan Q; Wang Y; Estensen RD; Young MR; Colburn NH; Yin H; Goodin C; Anderson MW; You M
Cancer Prev Res (Phila); 2010 Sep; 3(9):1148-56. PubMed ID: 20716630
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant.
Shimizu Y; Kinoshita I; Kikuchi J; Yamazaki K; Nishimura M; Birrer MJ; Dosaka-Akita H
Br J Cancer; 2008 Mar; 98(5):915-22. PubMed ID: 18283312
[TBL] [Abstract][Full Text] [Related]
18. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
[TBL] [Abstract][Full Text] [Related]
19. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
[TBL] [Abstract][Full Text] [Related]
20. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells.
Detry C; Lamour V; Castronovo V; Bellahcène A
Bone; 2008 Feb; 42(2):422-31. PubMed ID: 18088579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
